Literature DB >> 6372074

Different response of gastric inhibitory polypeptide to glucose and fat from duodenum and jejunum.

G Schattenmann, R Ebert, R Siewert, W Creutzfeldt.   

Abstract

Gastric inhibitory polypeptide (GIP), insulin, and blood glucose after ingestion of glucose or fat were examined in patients after gastrectomy with esophagojejunostomy or esophagoduodenostomy. After a glucose load patients without duodenal passage had significantly higher glucose and significantly smaller insulin levels than patients with duodenal passage. The fasting levels of serum immunoreactive GIP were moderately elevated and reached significantly higher levels after oral glucose ingestion in both gastrectomized groups as compared with normal subjects. In patients with preserved duodenal passage serum IR-GIP levels peaked earlier and were significantly higher than in patients without duodenal passage. In contrast to the finding after oral glucose ingestion, the IR-GIP response to an oral fat load was nearly twofold greater in patients without duodenal passage than in patients with duodenal continence. Thus, glucose-induced GIP release is mainly of duodenal and fat-induced GIP release mainly of jejunal origin. This suggests the existence of two types of GIP cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6372074

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  6 in total

Review 1.  Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery.

Authors:  David E Cummings; Joost Overduin; Karen E Foster-Schubert; Molly J Carlson
Journal:  Surg Obes Relat Dis       Date:  2007 Mar-Apr       Impact factor: 4.734

2.  The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes.

Authors:  Francesco Rubino; Antonello Forgione; David E Cummings; Michel Vix; Donatella Gnuli; Geltrude Mingrone; Marco Castagneto; Jacques Marescaux
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

Review 3.  New developments in the incretin concept.

Authors:  W Creutzfeldt; R Ebert
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

4.  Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome.

Authors:  B Gebhard; J J Holst; C Biegelmayer; J Miholic
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

5.  Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy.

Authors:  J Miholic; C Orskov; J J Holst; J Kotzerke; H J Meyer
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

6.  Incretin Kinetics Before and After Miglitol in Japanese Patients With Late Dumping Syndrome.

Authors:  Mari Amagai; Hirohisa Tsuchiya; Yukari Chiba; Jun Suzuki; Jo Nagakura; Erina Shigematsu; Tadashi Yamakawa; Yasuo Terauchi
Journal:  J Clin Med Res       Date:  2017-09-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.